一种新型人工智能辅助「血管愈合」诊断用于预测溃疡性结肠炎患者未来临床复发:前瞻性队列研究(附视频)
本研究开发基于8853张图像的人工智能系统诊断溃疡性结肠炎「血管愈合」,在前瞻性队列104例临床缓解患者中验证。人工智能判定血管活跃组临床复发率23.9%(16/67)显著高于血管愈合组3.0%(1/33),P=0.01。在MES≤1亚组中,完全内镜缓解联合血管愈合的ROC曲线下面积0.70高于单独完全内镜缓解的0.65。
要点
- 人工智能辅助血管愈合诊断系统基于167例患者8853张图像开发,用于预测溃疡性结肠炎临床复发。
- 104例临床缓解患者随访12个月,人工智能血管活跃组复发率23.9%,血管愈合组3.0%,P=0.01。
- MES≤1亚组中,完全内镜缓解联合血管愈合的ROC曲线下面积0.70,高于单独完全内镜缓解的0.65。
核心结论
- 人工智能血管愈合诊断系统可能有助于医生更准确地识别溃疡性结肠炎缓解期患者中可能复发而非保持稳定者。
研究设计与样本
- 开放标签前瞻性队列研究,分析104例临床缓解的溃疡性结肠炎患者。
- 人工智能系统基于167例患者8853张图像开发,用于判定目标黏膜为人工智能血管活跃或血管愈合。
- 每例患者记录6个结直肠节段的Mayo内镜评分、人工智能输出和组织学评估,随访12个月。
主要发现
- 临床复发率在人工智能血管活跃组为23.9%(16/67),显著高于人工智能血管愈合组的3.0%(1/33),P=0.01。
- 在预测MES≤1患者临床复发的亚组分析中,完全内镜缓解联合血管愈合的ROC曲线下面积为0.70,高于单独完全内镜缓解的0.65。
关键数值与推荐
- 临床复发定义为部分Mayo评分>2。
- 人工智能系统基于8853张图像来自167例溃疡性结肠炎患者开发。
- 每例患者评估6个结直肠节段的Mayo内镜评分、人工智能输出和组织学评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Image-enhanced endoscopy has attracted attention as a method for detecting inflammation and predicting outcomes in patients with ulcerative colitis (UC); however, the procedure requires specialist endoscopists. Artificial intelligence (AI)-assisted image-enhanced endoscopy may help nonexperts provide objective accurate predictions with the use of optical imaging. We aimed to develop a novel AI-based system using 8853 images from 167 patients with UC to diagnose "vascular-healing" and establish the role of AI-based vascular-healing for predicting the outcomes of patients with UC. METHODS: This open-label prospective cohort study analyzed data for 104 patients with UC in clinical remission. Endoscopists performed colonoscopy using the AI system, which identified the target mucosa as AI-based vascular-active or vascular-healing. Mayo endoscopic subscore (MES), AI outputs, and histologic assessment were recorded for 6 colorectal segments from each patient. Patients were followed up for 12 months. Clinical relapse was defined as a partial Mayo score >2 RESULTS: The clinical relapse rate was significantly higher in the AI-based vascular-active group (23.9% [16/67]) compared with the AI-based vascular-healing group (3.0% [1/33)]; P = .01). In a subanalysis predicting clinical relapse in patients with MES ≤1, the area under the receiver operating characteristic curve for the combination of complete endoscopic remission and vascular healing (0.70) was increased compared with that for complete endoscopic remission alone (0.65). CONCLUSIONS: AI-based vascular-healing diagnosis system may potentially be used to provide more confidence to physicians to accurately identify patients in remission of UC who would likely relapse rather than remain stable.
引用
- Kuroki T, Maeda Y, Kudo SE, et al. A novel artificial intelligence-assisted "vascular healing" diagnosis for prediction of future clinical relapse in patients with ulcerative colitis: a prospective cohort study (with video). Gastrointest Endosc. 2024. PMID: 38215859. doi:10.1016/j.gie.2024.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。